Document is current
Any future updates will be listed below
-
Authors
Kim, Hyun-Tae
Shin, Bong-Jin
Lee, Yeon-woo
Park, Hye-Jin
Park, Sun-Young
Hwang, Eui-Hyoung
Hwang, Man-Suk
Lee, Dong-Jun
Shin, Byung-Cheul https://orcid.org/0000-0002-0059-2689
-
Funding
Funding for this research was provided by:
US Pharmatech Korea Co.
- License Information
-
More Information
Article History
Received: 30 December 2025
Accepted: 6 July 2026
First Online: 16 July 2026
Declarations
Ethics approval and consent to participate: This clinical trial was approved by the Institutional Review Board of Pusan National University Korean Medicine Hospital (approval number: PNUKHIRB 2023-04-001). The study was conducted in accordance with the Declaration of Helsinki and the Korean Good Clinical Practice (KGCP) guidelines. Written informed consent was obtained from all participants prior to enrollment. Participant enrollment began on October 31, 2023, and the final study visit was completed on June 27, 2024.
Consent for publication: Not applicable. This manuscript does not contain any individual person’s identifiable data.
Competing interests: The authors declare no competing interests.
